menu
    • menu

    Company profile for Seikagaku

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    By developing and offering innovative pharmaceuticals focused on its core field of glycoscience, Seikagaku aims to develop its businesses as a Global Category Pharma that contributes to the health and wealth of people all over the world. A "global category pharma" is defined as a company that achieves international competitiveness by targeting its research and development toward a specialized field to develop new drugs for wor...
    By developing and offering innovative pharmaceuticals focused on its core field of glycoscience, Seikagaku aims to develop its businesses as a Global Category Pharma that contributes to the health and wealth of people all over the world. A "global category pharma" is defined as a company that achieves international competitiveness by targeting its research and development toward a specialized field to develop new drugs for world markets. This is one strategy for long-term success identified by the Ministry of Health, Labor and Welfare in their vision for Japan's pharmaceutical industry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seikagakujapan Flag
    Country
    Country
    Japan
    Address
    Address
    Marunouchi Center Building 10fl. 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 10...
    Telephone
    Telephone
    +81 3-5220-8950
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.seikagaku.co.jp/en/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ferring Presents SI-6603 Phase 3 Data At NASS 2024
    Ferring Presents SI-6603 Phase 3 Data At NASS 2024

    25 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240925222087/en

    BUSINESSWIRE
    25 Sep 2024
    Share Share
    Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, for Herniation
    Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, for Herniation

    24 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240624522187/en

    BUSINESSWIRE
    24 Jun 2024
    Share Share
    Ono and Seikagaku Announce a MFG and Marketing Approval in Japan for JOYCLU®
    Ono and Seikagaku Announce a MFG and Marketing Approval in Japan for JOYCLU®

    23 Mar 2021

    // PRESS RELEASE

    https://www.ono-pharma.com/sites/default/files/en/news/press/enews20210323.pdf

    PRESS RELEASE
    23 Mar 2021
    Share Share
    Ono & Seikagaku Announce the Results a PhIII Study in Japan of ONO-5704/SI-613
    Ono & Seikagaku Announce the Results a PhIII Study in Japan of ONO-5704/SI-613

    11 Jun 2020

    // PRESS RELEASE

    https://www.ono.co.jp/eng/news/pdf/sm_cn200611_2.pdf

    PRESS RELEASE
    11 Jun 2020
    Share Share
    Eisai & Seikagaku Enter into Agreement for the Co-devp, Mkt Alliance of SI-613
    Eisai & Seikagaku Enter into Agreement for the Co-devp, Mkt Alliance of SI-613

    01 Apr 2020

    // YAHOO

    https://au.finance.yahoo.com/news/eisai-seikagaku-enter-agreement-co-032300581.html

    YAHOO
    01 Apr 2020
    Share Share
    Ono takes a long look at Seikagaku arthritis candidate
    Ono takes a long look at Seikagaku arthritis candidate

    13 May 2017

    // Phil Taylor FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/ono-takes-a-long-look-at-seikagaku-arthritis-candidate

    Phil Taylor FIERCE BIOTECH
    13 May 2017
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Contact Seikagaku and get a quotation

    Seikagaku is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find Chondroitin Sulfate Sodium bulk with JDMF offered by Seikagaku

    Find Sodium Hyaluronate bulk with JDMF offered by Seikagaku

    Find Chondroitin Sulfate Sodium bulk with DMF offered by Seikagaku

    Find Chondroitin Sulfate Sodium bulk offered by Seikagaku

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search